Trubitsyna, N. P. Et Al. 2015. Implementing an optimised glucose-lowering strategy in daily medical practice with first- and second-line gliclazide MR 60 mg. 51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD) , (Stockholm, Sweden).

Trubitsyna, N. P., Shestakova, M. V., Piletic, M., Satman, I., & Leiter, L. A., (2015). Implementing an optimised glucose-lowering strategy in daily medical practice with first- and second-line gliclazide MR 60 mg . 51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Stockholm, Sweden

Trubitsyna, N. Et Al. "Implementing an optimised glucose-lowering strategy in daily medical practice with first- and second-line gliclazide MR 60 mg," 51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Stockholm, Sweden, 2015

Trubitsyna, N. P. Et Al. "Implementing an optimised glucose-lowering strategy in daily medical practice with first- and second-line gliclazide MR 60 mg." 51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD) , Stockholm, Sweden, 2015

Trubitsyna, N. P. Et Al. (2015) . "Implementing an optimised glucose-lowering strategy in daily medical practice with first- and second-line gliclazide MR 60 mg." 51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD) , Stockholm, Sweden.

@conferencepaper{conferencepaper, author={N. P. Trubitsyna Et Al. }, title={Implementing an optimised glucose-lowering strategy in daily medical practice with first- and second-line gliclazide MR 60 mg}, congress name={51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)}, city={Stockholm}, country={Sweden}, year={2015}}